REFERENCES
- Sterling K, Refetoff S, Selenkow HA: T3 thyrotoxicosis. Thyrotoxicosis due to elevated serum triiodothyronine levels. JAMA 213: 571–575, 1970
- Wahner HW, Gorman CA: Interpretation of serum tri-iodothyronine levels measured by the Sterling technic. N Engl J Med 284: 225–230, 1971
- Ivy HK, Wahner HW, Gorman CA: “Triiodothyronine (T3) toxicosis.” Its role in Graves' disease. Arch Intern Med 128: 529–534, 1971
- Hollander CS, Mitsuma T, Nihei N, et al: Clinical and laboratory observations in cases of triiodothyronine toxicosis confirmed by radioimmunoassay. Lancet 1: 609–611, 1972
- Sterling K: Thyroxine in blood. Mayo Clin Proc 39: 586–608, 1964
- Nicoloff JT, Dowling JT: Estimation of thyroxine distribution in man. J Clin Invest 47: 26–37, 1968
- Sterling K: The significance of circulating triiodothyronine. Recent Prog Horm Res 26: 249–274, 1970
- Woeber KA, Sobel RJ, Ingbar SH, et al: The peripheral metabolism of triiodothyronine in normal subjects and in patients with hyperthyroidism. J Clin Invest 49: 643–649, 1970
- McConnon J, Row VV, Volpé R: Simultaneous comparative studies of thyroxine and tri-iodothyronine distribution and disposal rates. J Endocrinol 51: 17–30, 1971
- Blackburn CM, McConahey WM, Keating FR Jr, et al: Calorigenic effects of single intravenous doses of 1-triiodothyronine and 1-thyroxine in myxedematous persons. J Clin Invest 33: 819–824, 1954
- Sterling K, Brenner MA, Newman ES: Conversion of thyroxine to triiodothyronine in normal human subjects. Science 169: 1099–1100, 1970
- Braverman LE, Ingbar SH, Sterling K: Conversion of thyroxine (T4) to triiodothyronine (T3) in athyreotic human subjects. J Clin Invest 49: 855–864, 1970
- Gharib H, Mayberry WE, Ryan RJ: Radioimmunoassay for triiodothyronine: A preliminary report. J Clin Endocrinol Metab 31: 709–712, 1970
- Gharib H, Ryan RJ, Mayberry WE, et al: Radioimmunoassay for triiodothyronine (T3). I. Affinity and specificity of the antibody for T3. J Clin Endocrinol Metab 33: 509–516, 1971
- Mitsuma T, Nihei N, Gershengorn MC, et al: Serum triiodothyronine: measurements in human serum by radioimmunoassay with corroboration by gas-liquid chromatography. J Clin Invest 50: 2679–2688, 1971
- Chopra IJ, Solomon DH, Beall GN: Radioimmunoassay for measurement of triiodothyronine in human serum. J Clin Invest 50: 2033–2041, 1971
- Lieblich J, Utiger RD: Triiodothyronine radioimmunoassay. J Clin Invest 51: 157–166, 1972
- Maclagan NF, Bowden CH, Wilkinson JH: The metabolism of thyroid hormones. 2. Detection of thyroxine and tri-iodothyronine in human plasma. Biochem J 67: 5–11, 1957
- Rupp JJ, Chavarria C, Paschkis KE, et al: The occurrence of tri-iodothyronine as the only circulating thyroid hormone. Ann Intern Med 51: 359–362, 1959
- Werner SC, Row W, Radichevich I: Nontoxic nodular goiter with formation and release of a compound with the chromatographic mobility characteristics of triiodothyronine. J Clin Endocrinol Metab 20: 1373–1383, 1960
- Shimaoka K: Toxic adenoma of the thyroid, with triiodothyronine as the principal circulating thyroid hormone. Acta Endocrinol (Kbh) 43: 285–293, 1963
- Stevenson RC, Pineda VG, Silva SE: Role of l-triiodothyronine in endemic goiter. Proceedings of the VII Pan American Congress of Endocrinology, Sao Paulo, August 16–21, 1970. Excerpta Medica International Congress Series No. 238, 1970, pp 142–150
- Wahner HW, Emslander RF, Gorman CA: Thyroid overactivity and TBG deficiency simulating “T3 hyperthyroidism.” J Clin Endocrinol Metab 33: 93–97, 1971